Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials.
dc.contributor.author | Dore, G. J. | |
dc.contributor.author | Conway, B. | |
dc.contributor.author | Luo, Y. | |
dc.contributor.author | Janczewska, E. | |
dc.contributor.author | Knysz, B. | |
dc.contributor.author | Liu, Y. | |
dc.contributor.author | Streinu-Cercel, A. | |
dc.contributor.author | Caruntu, F. A. | |
dc.contributor.author | Curescu, M. | |
dc.contributor.author | Soza, Alejandro | |
dc.date.accessioned | 2021-05-13T17:51:13Z | |
dc.date.available | 2021-05-13T17:51:13Z | |
dc.date.issued | 2016 | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1016/j.jhep.2015.08.015 | |
dc.identifier.eissn | 1600-0641 | |
dc.identifier.issn | 0168-8278 | |
dc.identifier.uri | https://doi.org/10.1016/j.jhep.2015.08.015 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/58305 | |
dc.issue.numero | No. 1 | |
dc.nota.acceso | Contenido completo | |
dc.pagina.final | 28 | |
dc.pagina.inicio | 19 | |
dc.revista | Journal of Hepatology | es_ES |
dc.rights | acceso abierto | |
dc.title | Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials. | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 64 | |
sipa.codpersvinculados | 461 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Efficacy and safety of ombitasvir-paritaprevir-r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients, The MALACHITE-I-II trials..pdf
- Size:
- 944.45 KB
- Format:
- Adobe Portable Document Format
- Description: